Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1121163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Yong-Liang Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Air Force Medical University (The Fourth Military Medical University), Xi'an, China. Hauptthemen laut MEDLINE: Hemorrhagic Fever Virus, Crimean-Congo, Hemorrhagic Fever, Crimean, Vaccines, DNA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Crimean-Congo hemorrhagic fever virus (CCHFV) can cause severe hemorrhagic fever in humans and is mainly transmitted by ticks. There is no effective vaccine for Crimean-Congo hemorrhagic fever (CCHF) at present. We developed three DNA vaccines encoding CCHFV nucleocapsid protein (NP), glycoprotein N-terminal (Gn) and C-terminal (Gc) fused with lysosome-associated membrane protein 1 (LAMP1) and assessed their immunogenicity and protective efficacy in a human MHC (HLA-A11/DR1) transgenic mouse model. The mice that were vaccinated three times with pVAX-LAMP1-CCHFV-NP induced balanced Th1 and Th2 responses and could most effectively protect mice from CCHFV transcription and entry-competent virus-like particles (tecVLPs) infection. The mice vaccinated with pVAX-LAMP1-CCHFV-Gc mainly elicited specific anti-Gc and neutralizing antibodies and provided a certain protection from CCHFV tecVLPs infection, but the protective efficacy was less than that of pVAX-LAMP1-CCHFV-NP. The mice vaccinated with pVAX-LAMP1-CCHFV-Gn only elicited specific anti-Gn antibodies and could not provide sufficient protection from CCHFV tecVLPs infection. These results suggest that pVAX-LAMP1-CCHFV-NP would be a potential and powerful candidate vaccine for CCHFV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Air Force Medical University (The Fourth Military Medical University), Xi'an, China.
- Department of Dermatology, The Eighth Medical Center of PLA General Hospital, Beijing, China.
- College of Life Sciences, Northwest University, Xi'an, China.
- School of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, China.
- Department of Immunology, Air Force Medical University (The Fourth Military Medical University), Xi'an, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hu, Y. L., Zhang, L. Q., Liu, X. Q., Ye, W., Zhao, Y. X., Zhang, L., Qiang, Z. X., Zhang, L. X., Lei, Y. F., Jiang, D. B., Cheng, L. F., & Zhang, F. L. (2023). Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1121163
Vancouver
Hu YL, Zhang LQ, Liu XQ, Ye W, Zhao YX, Zhang L, et al. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1121163
BibTeX
@article{Hu2023,
author = {Hu, Yong-Liang and Zhang, Lian-Qing and Liu, Xiao-Qian and Ye, Wei and Zhao, Yue-Xi and Zhang, Liang and Qiang, Zun-Xian and Zhang, Lin-Xuan and Lei, Ying-Feng and Jiang, Dong-Bo and Cheng, Lin-Feng and Zhang, Fang-Lin},
title = {Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1121163}
}
EUVIMED